Alpine Immune Sciences, Inc. (34LA.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 03:29PM CEST
| Previous close | 59.50 |
| Open | 59.00 |
| Bid | 59.00 x N/A |
| Ask | 60.50 x N/A |
| Day's range | 59.00 - 59.00 |
| 52-week range | 7.80 - 61.00 |
| Volume | |
| Avg. volume | 34 |
| Market cap | 4.093B |
| Beta (5Y monthly) | 0.97 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
Alpine Immune Sciences Inc (ALPN) Reports Q1 2024 Financials Amid Pending Acquisition by Vertex ...
Financial Performance Aligns with Analyst Projections Despite Revenue Dip
- Insider Monkey
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q1 2024 Earnings Call Transcript
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q1 2024 Earnings Call Transcript May 6, 2024 Vertex Pharmaceuticals Incorporated beats earnings expectations. Reported EPS is $4.76, expectations were $4.07. Vertex Pharmaceuticals Incorporated isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome […]
- Thomson Reuters StreetEvents
Q1 2024 Vertex Pharmaceuticals Inc Earnings Call
Q1 2024 Vertex Pharmaceuticals Inc Earnings Call
© 2024 Yahoo. All rights reserved.